Treatment of Invasive Fungal Infections is organized by Boston University School of Medicine Continuing Medical Education (BUSM CME) and will be held from Jun 08, 2018 - Jun 07, 2019.
The target audience for this medical event is infectious disease specialists, internal medicine specialists and other healthcare professionals involved in the treatment of patients with or at risk for invasive fungal infections. This CME Conference has been approved for a maximum of 0.50 AMA PRA Category 1 Credits.
Early diagnosis and treatment of invasive fungal infections are essential for optimal clinical outcomes. Selection of appropriate antifungal therapy requires careful consideration of several factors including causative pathogen, underlying disease, prior history of antifungal use, and drug-related factors (spectrum of activity, pharmacokinetic/pharmacodynamic parameters, and safety profile). This activity will review the treatment of select invasive fungal infections and important considerations when choosing antifungal therapy.
• Integrate the most recent evidence-based guidelines and pharmacokinetic/pharmacodynamic characteristics of antifungal agents into treatment decisions for patients with invasive fungal infections
Additional details will be posted as soon as they are available.